National Bank of Canada’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225M Sell
1,614,500
-285,561
-15% -$40M 0.2% 91
2025
Q4
$233M Buy
1,900,061
+448,367
+31% +$54.5M 0.21% 87
2025
Q3
$161M Buy
1,451,694
+164,182
+13% +$18.7M 0.16% 116
2025
Q2
$143M Sell
1,287,512
-338,738
-21% -$36.1M 0.14% 139
2025
Q1
$182M Buy
1,626,250
+107,964
+7% +$11.1M 0.19% 111
2024
Q4
$140M Sell
1,518,286
-150,753
-9% -$13.6M 0.15% 127
2024
Q3
$140M Sell
1,669,039
-2,592
-0.2% -$198K 0.16% 126
2024
Q2
$115M Buy
1,671,631
+860,256
+106% +$57.4M 0.16% 121
2024
Q1
$53.5M Sell
811,375
-354,458
-30% -$27.3M 0.08% 220
2023
Q4
$97M Buy
1,165,833
+123,985
+12% +$9.65M 0.16% 137
2023
Q3
$77.1M Buy
1,041,848
+36,772
+4% +$2.83M 0.12% 162
2023
Q2
$77.1M Buy
1,005,076
+349,774
+53% +$27.9M 0.14% 137
2023
Q1
$54.4M Buy
655,302
+226,864
+53% +$18.8M 0.13% 137
2022
Q4
$36.8M Buy
428,438
+255,126
+147% +$20.2M 0.09% 186
2022
Q3
$10.8M Sell
173,312
-404,737
-70% -$25.5M 0.06% 349
2022
Q2
$35.8M Buy
578,049
+389,051
+206% +$24.1M 0.16% 143
2022
Q1
$11.8M Sell
188,998
-322,240
-63% -$20.6M 0.04% 420
2021
Q4
$37.1M Buy
+511,238
New +$35.2M 0.13% 133

Other funds holding GILD

National Bank of Canada's GILD Position: Q1 2026 in Review

National Bank of Canada reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $40M and leaving 1,614,500 shares worth $225M. The position accounts for 0.2% of the portfolio, ranked #91.

National Bank of Canada first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $233M in Q4 2025. 2,313 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • National Bank of Canada held 1,614,500 shares of Gilead Sciences worth $225M as of Q1 2026.
  • National Bank of Canada sold 285,561 Gilead Sciences shares in Q1 2026, an estimated $40M.
  • Gilead Sciences made up 0.2% of National Bank of Canada's portfolio in Q1 2026, its #91 holding.
  • National Bank of Canada first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Gilead Sciences position peaked at $233M in Q4 2025.
  • 2,313 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.